Sofwave Medical reported Q2 2026 revenue of $30 million, a 43% year-over-year increase, reflecting robust adoption of its ultrasound-based microneedling platform. The company has been gaining traction in the competitive energy-device space against RF and laser competitors.
Devices & Tech
Sofwave Q2 Revenue Jumps 43% YoY to $30M
Ultrasound microneedling device maker posts strong growth, signaling sustained demand for energy-based platforms.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Sofwave posts 43% YoY growth, signaling sustained demand for ultrasound microneedling over RF and laser.
For practice owners evaluating device acquisition, Sofwave's trajectory matters. Ultrasound microneedling offers a differentiated mechanism—mechanical disruption plus thermal energy at controlled depth—without the downtime or tissue damage risk of aggressive RF. The 43% growth suggests practices are rotating capital toward this modality, likely for skin tightening and collagen remodeling in the face and neck. Device leasing and per-treatment economics will be key; strong manufacturer revenue growth often precedes price increases or tighter rebate terms. Practices should benchmark current lease rates and utilization thresholds before rates shift.
Source: original report ↗
Frequently asked questions
What is ultrasound microneedling and how does it differ from RF or laser?
Ultrasound microneedling combines mechanical disruption with thermal energy at controlled depth, offering skin tightening and collagen remodeling without the downtime or tissue damage risk of aggressive RF. Sofwave's platform uses ultrasound-based technology as its differentiated mechanism in the energy-device space.
Why is Sofwave's 43% revenue growth significant for medspa owners?
The 43% YoY revenue jump to $30M signals sustained market demand for ultrasound microneedling and suggests practices are rotating capital toward this modality. Strong manufacturer growth often precedes price increases or tighter rebate terms, making it critical for owners to benchmark lease rates now before terms shift.
Should I lease or buy a Sofwave device for my practice?
Device leasing and per-treatment economics are key considerations. With Sofwave experiencing rapid growth, current lease rates and utilization thresholds should be benchmarked immediately, as strong manufacturer revenue growth typically leads to price increases or less favorable rebate terms in the near term.
What body areas does ultrasound microneedling treat best?
Ultrasound microneedling is primarily used for skin tightening and collagen remodeling in the face and neck. The controlled-depth thermal and mechanical energy makes it effective for these areas without the recovery burden of more aggressive energy platforms.
How does Sofwave's growth compare to other energy-based device makers?
Sofwave posted 43% YoY growth in Q2 2026 to $30M revenue, positioning it as a strong competitor against RF and laser platforms. This trajectory reflects robust adoption of its differentiated ultrasound-based mechanism and suggests market share gains in the energy-device space.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.